尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Gotto Antonio M Jr Md d Phil, 董事. Insider active across 1 company, notably Esperion Therapeutics, Inc.. In total, 3 reports have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 23 May 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Antonio M. Gotto Jr, MD D Phil is a Director at Esperion Therapeutics, Inc. In this role, he participates in the governance and oversight of the company's activities. Esperion is a biopharmaceutical company. Antonio brings expertise in research and development as well as corporate strategy.